person · Reporting owner
MINOCHERHOMJEE ARDA PHD
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ReShape Weightloss Inc.RSLS · Entity 137993 | Director | August 13, 2018 | August 29, 2018 |
| Vyome Holdings, IncRSLS · Entity 1824 | Director | July 22, 2021 | September 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ReShape Weightloss Inc.
Report date August 13, 2018 · Filed August 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2018-08-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Vyome Holdings, Inc
Report date July 22, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 253,429 |
Reported balance
After 2021-07-22 transaction · row 1
1 source rowRow 1 · 2021-07-22 · Grant · Acquired 253,429 · Balance 253,429 F1: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2021 Filed Sep 17, 2021 22:18 UTC | Vyome Holdings, Inc RSLS · Entity 1824 | GrantCommon Stock, $0.001 par value per share | 253,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001790300-21-000007 · primary_doc.xml · nonDerivative · entry 1 MINOCHERHOMJEE ARDA PHD · CIK 0001288238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,429 F1 · shares: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.